Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Molina (MOH) Stock Surges 34% In A Year: More Room To Run

Published 07/08/2019, 10:16 PM
Updated 07/09/2023, 06:31 AM
AAPL
-
UNH
-
MOH
-
HCA
-
WCG
-

Molina Healthcare, Inc (NYSE:MOH) has been in investors’ good books on the back of a solid revenue stream and restructuring strategies.

In 2018, net income came in at $10.61 per share against net loss of $9.07 in 2017. This upside can mainly be attributed to a decline in the medical care ratio and the general and administrative expense ratio.

In a year’s time, this Zacks Rank #1 (Strong Buy) company has rallied 34% versus its industry’s dip of 2.5%. Moreover, it has witnessed its 2020 earnings estimates move north over the past seven days.



Its return on equity — a profitability measure — stands at 49.2%, higher than the industry's average of 23.1%.

The stock carries an impressive VGM Score of A. Here V stands for Value, G for Growth and M for Momentum with the score being a weighted combination of all three factors.

We expect the momentum to continue as it gains from the following factors:

Promising Top Line: The company has seen consistent growth in its revenue base over the past several years (CAGR of 27.4% from 2012-2017). Although the metric decreased to some extent last year due to both lower premium revenues and premium tax revenues, the same again rose 11.3% in the first quarter of 2019. The top-line boost is primarily attributable to the company’s premium revenues, which have grown consistently over the past many years. Given the restructuring plans and developmental strategies, we expect revenues to augment steadily going forward. For 2019, the company’s total revenues are projected at $16.4 billion, higher than the previous expectation of $16.3 billion.

Restructuring Initiative: Molina has been gaining from the restructuring and profitability improvement plan, which started in 2017. The plan included streamlining of organizational structure to improve efficiency as well as the speed and quality of decision-making. This endeavor has led to a total expense decline by 13.2%, each in 2018 and during the first quarter of 2019. As part of this effort, the company sold its units — Pathways Health and Community Support, LLC and Molina Medicaid Solutions — which will help it focus on the core growth areas.

Reduced Debt Level: In 2018, the company managed to lower its long-term debt level by 22.6% year over year. As a result, interest expenses of the company also declined to some extent, which remains a positive for the company.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Zacks Consensus Estimate for current-year earnings is pegged at $10.93, indicating an increase of 3% from the year-ago reported figure.

For 2020, the Zacks Consensus Estimate for earnings stands at $11.78 on $17.77 billion revenues, implying a respective 7.7% and 8.4% improvement from the prior-year reported numbers.

Other Key Picks

Investors interested in the medical sector can also take a look at some other top-ranked stocks like WellCare Health Plans, Inc. (NYSE:WCG) , UnitedHealth Group Incorporated (NYSE:UNH) and HCA Healthcare, Inc. (NYSE:HCA) . You can see the complete list of today’s Zacks #1 Rank stocks here.

WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 13.52% in the preceding four quarters. It sports a Zacks Rank of 1.

UnitedHealth works as a diversified health care company and carries a Zacks Rank #2 (Buy). It came up with average four-quarter positive surprise of 3.27%.

HCA Healthcare provides health care services. In the last four quarters, the company delivered average beat of 15.74%. It is a Zacks #1 Ranked player.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.